Reverse Merger Services Going Public

February 8, 2010

HCEI, Healthy Coffee Announces Fourth Quarter Results as of December 31, 2009 - DrStockPick.com Stock Report!

Filed under: Uncategorized — Tags: , , — The Editor @ 2:03 pm

_________________________________________

drstock-2-3

FREE Daily Stock Alerts From DrStockPick.com

signup3m

_________________________________________

Monday Feb. 08, 2010

DrStockPick.com Stock Report!

HCEI, Healthy Coffee International Inc., HCEI.PK

**************************************************************

hceilogo

Healthy Coffee Announces Fourth Quarter Results as of December 31, 2009

NEWPORT BEACH, CA–(CRWENEWSWIRE) - Feb. 08, 2010 - Healthy Coffee International, Inc. (Pinksheets:HCEI) announced today that the company posted almost $1 million of sales revenues and approximately $150,000 in profits as of December 2009. Exact figures will soon be reported in the company’s fourth quarter financials.

ABOUT HEALTHY COFFEE INTERNATIONAL, INC.

Healthy Coffee International, Inc., category creator of Healthy Coffee, is focused on bringing health to the world’s largest and most popular drink, coffee. The company’s proprietary formulas combine the health benefits of Ginseng, Reishi Mushroom, and other top quality ingredients with the world’s finest coffee beans to create a line of deliciously healthy instant gourmet coffee drinks. Healthy Coffee is well positioned in the market place at the intersection of three mega-billion dollar industries: coffee, wellness and energy drinks, and has quickly established offices in11 countries and distributors in 29 other countries through its marketing subsidiary Healthy Coffee USA, Inc. (www.HealthyCoffee.com) which uses a simple and unique Internet-driven international business model that allows the average person to own and operate a local, national, or international coffee distribution or coffee house business with very little capital investment or overhead. For more information, visit www.HCEI.biz.

Safe Harbor Statement: This release contains forward-looking statements with respect to the results of operations and business of Healthy Coffee International, Inc., which involves risks and uncertainties. The Company’s actual future results could materially differ from those discussed. The Company intends that such statements about the Company’s future expectations, including future revenues and earnings, and all other forward looking statements be subject to the “Safe Harbors” provision of the Private Securities Litigation Reform Act of 1995.

Contact:
Rick Aguiluz
CEO
Healthy Coffee International, Inc.
(949) 209-8850

Source: Healthy Coffee International

**************************************************************

***********Advertisement***********

stockir2

crweresearch

crwedomains

crwects

promolinks3
crwenewswire crwenews hototc penstox crwefinance stockhottips beststockreport cohenresearch crweselect bestotc stockegg xplosivestocks crwepicks stock-pr coolpennystocks pennyinvest crwewallstreet drstockpick stockrich worldstockwire pennyomega ctsproducts nanocapgems pennytobuck crowntradingsystems momentumtraders otcsignal doubleinstocks titanstocks bestdamnpennystocks princetonresearch shakerzandmoverz nebulastocks stockmarketinginc pennystockchaser isg pennystockfarm powerpennyplays stockfrontrunners.com

malonebailey

wfllc

********************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com End Of day publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.

Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick Stock Watch report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur.

Disclaimer: Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. (read more) Rule 17B requires disclosure of payment for investor relations.

_______________________________________________________

signup3m

_______________________________________________________

dr12

Dr. Stock Pick is a seasoned equity trader and financial investor. He’s on the Crown Equity Holdings, Inc (CRWE.OB) financial staff as a professional investment analyst and consultant. He’s syndicated on over 1000 websites www.crwenews.com, www.stock-ir.com, www.PennyOmega.com, www.PennyToBuck.com, giving daily, up to the minute information about stocks, options, currencies and more. www.drstockpick.com

email: investor@drstockpick.com

ctse16

Dr Stock Pick would like to invite you to www.crowntradingsystems.com so you can check out the super 16 multi monitor super computer he trades on daily. If you’re looking for a multi display computer to enhance your trading then you’ll want to visit www.crowntradingsystems.com

CSRH, - Consorteum Holdings’ $1,000,000 Private Placement Financing will Begin this Month - DrStockPick.com Stock Report!

_________________________________________

drstock-2-3

FREE Daily Stock Alerts From DrStockPick.com

signup3m

_________________________________________

Monday Feb. 08, 2010

DrStockPick.com Stock Report!

**************************************************************

csrh CSRH, Consorteum Holdings Inc, CSRH.OB

CSRH will build on its extensive expertise within the Payments and Transaction Industry in North America, Europe, and internationally by identifying new technologies and trends in the changing global marketplace, Consorteum Holdings Inc. aims to increase revenues in existing markets, enter new markets, and deliver unique products and services more effectively and efficiently. Each program and initiative launched is designed to drive additional transaction based, long-term revenues and increased shareholder value. Consorteum Holdings Inc. has built its reputation with one goal, “For our customers to look at us as partners, not just a technology provider.”

Recently, CSRH reported that it has reached an agreement to raise additional financing with private investors who already have an investment interest in the company. This agreement will provide for an initial investment of up to $1,000,000 USD in the first two fiscal quarters of 2010.

The funds received will enhance the delivery schedules of current contracts as well as provide for the pursuit of additional contracts in North American and International markets. This marks the first 2010 financial engagement for CSRH as it positions its focus on new market opportunities for the New Year.

Craig Fielding, CEO of CSRH states, “The market for our solutions is expanding rapidly. With full expectations of additional growth in our contract portfolio this year, this infusion allows us to pursue these opportunities more aggressively.”

The funding will begin in February 2010 on a draw down basis at CSRH’s discretion to allow the Company to take full advantage of new business opportunities.

More about CSRH at www.consorteum.com

**************************************************************

drstbc

**************************************************************

***********Advertisement***********

stockir2

crweresearch

crwedomains

crwects

promolinks3
crwenewswire crwenews hototc penstox crwefinance stockhottips beststockreport cohenresearch crweselect bestotc stockegg xplosivestocks crwepicks stock-pr coolpennystocks pennyinvest crwewallstreet drstockpick stockrich worldstockwire pennyomega ctsproducts nanocapgems pennytobuck crowntradingsystems momentumtraders otcsignal doubleinstocks titanstocks bestdamnpennystocks princetonresearch shakerzandmoverz nebulastocks stockmarketinginc pennystockchaser isg pennystockfarm powerpennyplays stockfrontrunners.com

malonebailey

wfllc

********************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com End Of day publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.

Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick Stock Watch report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur.

Disclaimer: Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. (read more) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) has received five thousand dollars from Consorteum Holdings Inc. for 30 days of advertisement services. Crown Equity Holdings, Inc. (CRWE.OB) has received 78,000 free trading and 500,000 144 (restricted) shares from a third party for 6 months of advertising services for Consorteum Holdings Inc, (CSRH.OB).

_______________________________________________________

signup3m

_______________________________________________________

dr12

Dr. Stock Pick is a seasoned equity trader and financial investor. He’s on the Crown Equity Holdings, Inc (CRWE.OB) financial staff as a professional investment analyst and consultant. He’s syndicated on over 1000 websites www.crwenews.com, www.stock-ir.com, www.PennyOmega.com, www.PennyToBuck.com, giving daily, up to the minute information about stocks, options, currencies and more. www.drstockpick.com

email: investor@drstockpick.com

ctse16

Dr Stock Pick would like to invite you to www.crowntradingsystems.com so you can check out the super 16 multi monitor super computer he trades on daily. If you’re looking for a multi display computer to enhance your trading then you’ll want to visit www.crowntradingsystems.com

CVAT, Cavitation Technologies is Increasing its Market Opportunity Exponentially - DrStockPick.com Stock Report!

Dr Stock Pick HOT News & Alerts!

_________________________________________

drstock-2-3

FREE Daily Stock Alerts From DrStockPick.com

signup3m

_________________________________________

Monday Feb. 08, 2010

DrStockPick.com Stock Report!

**************************************************************

cvat2 CVAT, Cavitation Technologies, Inc., CVAT.OB

CVAT is a “Green-Tech” company, established in 2006 to become a world leader in the development of new cutting edge technologies for the vegetable oil refining, renewable fuel, petroleum, water treatment, wastewater sanitation, food and beverage, and chemical industries.

Recently, CVAT reported executing a Worldwide License and Distribution Agreement for CVAT’s Green D Plus Nano Cavitation Reactor Systems with Desmet Ballestra Group, which is the market leader providing the most advanced and efficient processing equipment and systems to the $100 Billion Dollar a year food oil extraction and refining industry.

Conservatively estimated, implementation of CVAT’s Green D Plus Nano Cavitation Technology will save the industry more than $70 Million USD every year for soy and canola installations alone.

CVAT projects significant revenue within the next 12 months having initial commitment for at least 20 plant installations annually.

Furthermore, CVAT has entered into a Strategic Alliance Agreement with Divine Fuel, LLC with regard to CVAT’s BioForce 9000 renewable fuel systems.

Divine Fuel, LLC is a project development company focused on renewable fuels production in Mexico, Guatemala and Peru. After evaluating all available technologies, Divine Fuel selected CVAT’s advanced BioForce 9000 system as the technology of choice.

Divine Fuel, LLC has commitments for its first 100 million gallon per year biofuel plant and letters of intent for building nine additional 100 million gallon plants to be constructed over the next three to five years.

As you’ve just read, CVAT is increasing its Market Opportunity exponentially with these kind of agreements, that could increase in the same way its revenue.

With Its Technologies, CVAT has a HUGE Potential of great upside!!

More about CVAT at www.cavitationtechnologies.com

**************************************************************

drstbc

**************************************************************

***********Advertisement***********

stockir2

crweresearch

crwedomains

crwects

promolinks3
crwenewswire crwenews hototc penstox crwefinance stockhottips beststockreport cohenresearch crweselect bestotc stockegg xplosivestocks crwepicks stock-pr coolpennystocks pennyinvest crwewallstreet drstockpick stockrich worldstockwire pennyomega ctsproducts nanocapgems pennytobuck crowntradingsystems momentumtraders otcsignal doubleinstocks titanstocks bestdamnpennystocks princetonresearch shakerzandmoverz nebulastocks stockmarketinginc pennystockchaser isg pennystockfarm powerpennyplays stockfrontrunners.com

malonebailey

wfllc

********************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com End Of day publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.

Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick Stock Watch report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur.

Disclaimer: Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. (read more) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) anticipates receiving sixty thousand dollars in 144 restricted stock for twelve months of advertisement services for Cavitation Technologies, Inc. (CVAT.OB)

_______________________________________________________

signup3m

_______________________________________________________

dr12

Dr. Stock Pick is a seasoned equity trader and financial investor. He’s on the Crown Equity Holdings, Inc (CRWE.OB) financial staff as a professional investment analyst and consultant. He’s syndicated on over 1000 websites www.crwenews.com, www.stock-ir.com, www.PennyToBuck.com, www.PennyOmega.com, giving daily, up to the minute information about stocks, options, currencies and more. www.drstockpick.com

email: investor@drstockpick.com

 

ctse16

Dr Stock Pick would like to invite you to www.crowntradingsystems.com so you can check out the super 16 multi monitor super computer he trades on daily. If you’re looking for a multi display computer to enhance your trading then you’ll want to visit www.crowntradingsystems.com

PWRM, HEB, DrStockPick.com Stock Report! on Monday Feb. 08, 2010, Power 3 Medical Products Inc. and Hemispherx Biopharma, Inc.

Filed under: Uncategorized — Tags: , , , , — The Editor @ 10:42 am

Dr Stock Pick HOT News & Alerts!

_________________________________________

drstock-2-3

FREE Daily Stock Alerts From DrStockPick.com

signup3m

_________________________________________

Monday Feb. 08, 2010

DrStockPick.com Stock Report!

**************************************************************

PWRM, Power 3 Medical Products Inc., PWRM.OB

PWRM is a leader in bio-medical research and the commercialization of neurodegenerative disease and cancer biomarkers, pathways, and mechanisms of diseases through the development of diagnostic tests and drug targets. PWRM’s patent-pending technologies are being used to develop screening and diagnostic tests for the early detection and prognosis of disease, identify protein biomarkers, and drug targets, and its diagnostic tests are targeted toward markets with critical unmet needs in areas including neurodegenerative disease (NuroPro) and breast cancer (BC-SeraPro). PWRM operates a state-of-the-art CLIA certified laboratory in The Woodlands (Houston), Texas and continues to evolve and enhance its IP portfolio, employing sensitive and specific combinations of biomarkers it has discovered from a broad range of diseases as the basis of highly selective blood-based tests for ALS, Alzheimer’s, and Parkinson’s diseases, breast cancer, and drug resistance.

** PWRM reported that 4 abstracts covering results from clinical validation trials of the NuroPro(R) AD test for Alzheimer’s disease were submitted to the 2010 annual meeting of the International Congress of Alzheimer’s Disease, taking place July 2010. The NuroPro AD test was developed to help clinicians distinguish patients with Alzheimer’s disease from “normal” individuals and patients with other neurological disorders. The test, developed by Power3, is a panel of 57 blood serum protein biomarkers evaluated by biostatistical analysis to predict the probability a patient has Alzheimer’s disease. The test is intended to solve the critical challenge facing physicians, clinicians, and patients for quick, early stage, and accurate diagnosis of this debilitating disease as well as to provide guidance for therapy, and monitor treatment response.

The four studies present the capabilities of NuroPro for accurate diagnosis, targeted therapy and drug response monitoring. They involve a total of 154 Alzheimer’s disease and 91 Parkinson’s disease patients, 210 age-matched normal and 173 disease control individuals. The abstracts report the combined results from the clinical validation trials of the NuroPro(R) AD and NuroPro PD tests, conducted by the PWRM scientific team, led by medical director Lourdes R. Bosquez, MD and chief scientific officer, Ira L. Goldknopf, Ph.D., in collaboration with Marwan Sabbagh, MD, director of the Banner Sun Health Research Institute, Sun City, Arizona, Katerina Markopoulou, M.D., Assistant Professor of Neurology at the University of Thessaly, Larissa Greece, along with previous studies Power3 conducted with Stanley H. Appel, MD during his tenure as Chairman of Neurology, Baylor College of Medicine, Houston TX. Dr. Appel is now Co-Director of the Methodist Neurological Research Institute, Houston, TX, and continues to be chairman of the scientific advisory board of Power3.

More about PWRM at www.Power3Medical.com

**************************************************************

HEB, Hemispherx Biopharma, Inc.

HEB is an advanced specialty pharmaceutical company engaged in the manufacture and clinical development of new drug entities for treatment of seriously debilitating disorders.

HEB reported a recent study, published in the December 20th issue of Virology (2009) by a consortium of researchers at Utah State University and the University of North Carolina, on a newly developed animal model of severe acute respiratory disease syndrome (SARS) which, according to the authors, ” … largely mimicked human disease”. SARS emerged in 2002 in the Guangdong province of Southern China as a new infectious respiratory disease characterized by influenza-like symptoms with a very high mortality rate. The researchers characterized and adapted a new strain of the SARS virus (SARS-CoV) to mice that was 100% lethal and was associated with the overproduction of cytokines and severe lung pathology (Day CW, et al. Virology, 395:210-222, 2009).

Multiple agents with purported antiviral activity were evaluated for activity in this unique mouse model of the human disease, including Ampligen(R) (Poly I : Poly C12U), ribavirin (a commercially available antiviral with multiple modes of action for certain respiratory diseases) and other experimental agents. The researchers found that, uniquely among the agents tested, Ampligen(R), an experimental therapeutic, ” … protected against death and gross damage to the lungs in the presence of lethal SARS-CoV” and was associated with a reduction in IL-6 concentration in which high levels of the cytokine correlated with the mortality of SARS-CoV infection. Mortality was high, under the conditions tested, for all the other antiviral agents examined, including ribavirin, that have previously been used extensively in humans with SARS without definitive evidence of efficacy (Stockman LJ, et al. PLoS Med 3 (9),e 343).

To date, there are no approved agents for treating SARS. Animal experiments do not necessarily predict safety or efficacy in man. Encouraged by these results, HEB is now in discussions with Chinese clinical research organizations to institute clinical antiviral programs in China.

More about HEB at www.hemispherx.net.

**************************************************************

Keep a close eye on PWRM and HEB, do your homework, and like always BE READY for the ACTION!

**************************************************************

drstbc

**************************************************************

***********Advertisement***********

stockir2

crweresearch

crwedomains

crwects

promolinks3
crwenewswire crwenews hototc penstox crwefinance stockhottips beststockreport cohenresearch crweselect bestotc stockegg xplosivestocks crwepicks stock-pr coolpennystocks pennyinvest crwewallstreet drstockpick stockrich worldstockwire pennyomega ctsproducts nanocapgems pennytobuck crowntradingsystems momentumtraders otcsignal doubleinstocks titanstocks bestdamnpennystocks princetonresearch shakerzandmoverz nebulastocks stockmarketinginc pennystockchaser isg pennystockfarm powerpennyplays stockfrontrunners.com

malonebailey

wfllc

********************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com End Of day publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.

Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick Stock Watch report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur.

Disclaimer: Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. (read more) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) has previously received five hundred thousand shares compensation for 30 days of advertisement services and it has received an additional 1,000,000 shares 144 restricted stocks for 6 months of advertisement and diseminate news and $15,000 dollars for IR services for Power 3 Medical Products Inc. (PWRM.OB).

_______________________________________________________

signup3m

_______________________________________________________

dr12

Dr. Stock Pick is a seasoned equity trader and financial investor. He’s on the Crown Equity Holdings, Inc (CRWE.OB) financial staff as a professional investment analyst and consultant. He’s syndicated on over 1400 websites www.crwenews.com, www.stock-ir.com, www.PennyOmega.com, www.PennyToBuck.com, www.BestOTC.com, www.stock-pr.com giving daily, up to the minute information about stocks, options, currencies and more. www.drstockpick.com

email: investor@drstockpick.com

 

ctse16

Dr Stock Pick would like to invite you to www.crowntradingsystems.com so you can check out the super 16 multi monitor super computer he trades on daily. If you’re looking for a multi display computer to enhance your trading then you’ll want to visit www.crowntradingsystems.com

TAXS, TaxMasters, Inc. is Increasing its Revenues, Helping People to Reduce and Eliminate Federal Tax Debt

Filed under: Uncategorized — Tags: , , , , , — The Editor @ 9:26 am

Dr Stock Pick HOT News & Alerts!

_________________________________________

drstock-2-3

FREE Daily Stock Alerts From DrStockPick.com

signup3m

_________________________________________

Monday Feb. 08, 2010

DrStockPick.com Stock Report!

**************************************************************

taxslogo TAXS, TaxMasters, Inc., TAXS.OB

TAXS,the IRS tax relief company, is the first publicly traded tax resolution firm in the United States. Started by Patrick R. Cox in 2001, TAXS offers services and counsel to taxpayers across the country facing seemingly insurmountable tax problems, and relief from substantial federal tax debt.

Employing over 300 tax resolution experts, TAXS leverages the expertise of ex- IRS agents, enrolled agents, attorneys, CPAs, and seasoned tax consultants ready to counsel and assist every day people with their specific tax issues today.

Last December, TAXS reported financial results for the first nine months of 2009. Revenues totaled approximately $27 million, an increase of 87% over revenues of approximately $14 million in the same period of 2008. Net income for the nine month period was approximately $6 million, compared to approximately $1 million for the same period of 2008, an increase of nearly 442%. TAXS expects to report its financial results for the fourth quarter and full year 2009 on March 31, 2010.

In addition, TAXS has added 107 new employees in the last year, a 53% increase, bringing its total employees to 307. TAXS is staffing up to address expected strong demand for its tax relief services in the first quarter.

TAXS’ strategic plan for 2010 will leverage the increased demand for tax preparation and relief services in the first quarter of the year ahead of the IRS’s April 15th deadline. Given the economic climate that plagued much of 2009 and recent moves in the IRS to attempt to improve revenue collection methods, TAXS expects demand for services to continue to increase beyond the first quarter and throughout 2010.

This plan includes a number of changes and initiatives designed to meet the TAXS’ growth, including relocation to a larger office in the Houston area to accommodate new personnel and increased targeted advertising in 2010. TAXS will also continue to institute organizational changes begun in the second quarter of 2009 that are a result of its proprietary and internal Processes, Procedures, and Policies (P3) system. The resulting changes are designed to increase and streamline productivity, while also improving speed of service and customer service management.

With the April 15th filing deadline approaching rapidly, TAXS ‘ Founder, President and Board Chairman Patrick Cox Shares Tips for Selecting a Tax Preparer for 2010 Tax Season:

Cox suggests the following steps when choosing a tax preparer:

* Look for a robust and established practice: “Tax preparers that guarantee a return, or over promise what they can do for you should be a red flag for tax payers,” says Cox. “If what the preparer is saying to you seems too good to be true, it probably is.”

* Look for someone familiar with your profession, industry or status: “The kind of deductions you qualify for can largely depend on what you do for a living,” Cox says. “Preparers who have experience dealing with police officers, teachers, consultants or military service people are going to best understand the deductions and be able to guide you on what to claim.”

* Listen to word-of mouth and referrals: “A great way to find a reputable preparer is to ask a trusted family member or friend. People tend to refer others to tax preparers they can trust, or warn them if they caused problems,” says Cox.

More about TAXS at www.txmstr.com

**************************************************************

drstbc

**************************************************************

***********Advertisement***********

stockir2

crweresearch

crwedomains

crwects

promolinks3
crwenewswire crwenews hototc penstox crwefinance stockhottips beststockreport cohenresearch crweselect bestotc stockegg xplosivestocks crwepicks stock-pr coolpennystocks pennyinvest crwewallstreet drstockpick stockrich worldstockwire pennyomega ctsproducts nanocapgems pennytobuck crowntradingsystems momentumtraders otcsignal doubleinstocks titanstocks bestdamnpennystocks princetonresearch shakerzandmoverz nebulastocks stockmarketinginc pennystockchaser isg pennystockfarm powerpennyplays stockfrontrunners.com

malonebailey

wfllc

********************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com End Of day publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.

Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick Stock Watch report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur.

Disclaimer: Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. (read more) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) has previously received twenty four thousand dollars from Tax Masters Inc.(TAXS.OB) for 30 days of advertisement services. Crown Equity Holdings, Inc. (CRWE.OB) has received four thousand dollars from a third party (Marshall Curtis) for 30 days of advertisement services for Tax Masters Inc. (TAXS.OB).

_______________________________________________________

signup3m

_______________________________________________________

dr12

Dr. Stock Pick is a seasoned equity trader and financial investor. He’s on the Crown Equity Holdings, Inc (CRWE.OB) financial staff as a professional investment analyst and consultant. He’s syndicated on over 1000 websites www.crwenews.com, www.stock-ir.com, www.PennyToBuck.com, www.PennyOmega.com, giving daily, up to the minute information about stocks, options, currencies and more. www.drstockpick.com

email: investor@drstockpick.com

ctse16

Dr Stock Pick would like to invite you to www.crowntradingsystems.com so you can check out the super 16 multi monitor super computer he trades on daily. If you’re looking for a multi display computer to enhance your trading then you’ll want to visit www.crowntradingsystems.com

Older Posts »

Powered by WordPress